Verastem
VSTM
90 hedge funds and large institutions have $155M invested in Verastem in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 8 closing their positions.
105% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 20
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
5% more funds holding
Funds holding: 86 → 90 (+4)
23% less capital invested
Capital invested by funds: $201M → $155M (-$45.6M)
91% less call options, than puts
Call options by funds: $17K | Put options by funds: $196K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
+$1.49M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.35M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.11M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$1.02M |
| 5 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
+$881K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$1.21M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$538K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$469K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$466K |
| 5 |
JP Morgan Chase
New York
|
-$458K |
VSTM Hedge Fund Activity: Q2 2015 in Review
90 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q2 2015, worth a combined $155M — down 23% from $201M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VSTM positions and 8 closed out — a net gain of 4 holders — while 41 added to existing stakes and 20 trimmed.
The largest buyer was Axa, adding an estimated $1.49M. The largest seller was Wells Fargo, cutting an estimated $1.21M.
- 90 institutional investors held Verastem (VSTM) as of Q2 2015, up from 86 in Q1 2015.
- Funds reported $155M of Verastem stock for Q2 2015, down 23% quarter-over-quarter.
- 12 funds opened new Verastem positions in Q2 2015 and 8 closed out, a net change of +4 holders.
- The largest Verastem buyer in Q2 2015 was Axa, an estimated $1.49M added.
- The largest Verastem seller in Q2 2015 was Wells Fargo, an estimated $1.21M sold.
Based on aggregated 13F filings for Q2 2015.